-
-
-
-
-
-
-
Karyopharm Announces Strategic Financing Transactions to Support Growth; Extends Cash Runway Into Second Quarter of 2026, Beyond Expected Top-Line Readout of Phase 3 SENTRY Trial in Myelofibrosis
-
-
-
-
-
-
-
Biotech sector Q1 earnings preview from RBC Capital Markets
-
-
-
-
-
-
-
Karyopharm to Report Third Quarter 2024 Financial Results on November 5, 2024
-
-
-
-
-
-
-
Karyopharm Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress
-
-
-
-
-
-
-
Karyopharm to Report Third Quarter 2023 Financial Results on November 2, 2023
-
-
-
-
-
-
-
Karyopharm Therapeutics (KPTI) Misses Q4 EPS by 8c
-
-
-
-
-
-
-
Karyopharm to Report Second Quarter 2022 Financial Results on August 4, 2022
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

